Towards a stakeholders' consensus on patient payment policy: the views of health-care consumers, providers, insurers and policy makers in six Central and Eastern European countries

Abstract Background: The objective of this work was to analyse the prevalence trends of multimorbidity among European community-dwelling adults.Methods: A temporal series study based on waves 1, 2, 4, 5, 6 and 7 of the Survey of Health, Ageing and Retirement in Europe (SHARE) was conducted, and community-dwelling participants aged 50+ (n=274,614) from 15 European countries were selected, for the period 2004-2017. Prevalence, adjusted by age, Annual Percentage Change (APC) and 95% confidence interval (95% CI) were all calculated. Trend analyses were realised by period, age groups and groups of diseases. Results: The results showed a large variability in the prevalence of multimorbidity in adults aged 50 and over among European countries. Increase in the prevalence of multimorbidity in the countries of central Europe (Austria, Belgium, Czech Republic, France, Germany and Switzerland) and Spain in both sexes, and in the Netherlands among men. Stability was observed in northern and eastern European countries. Musculoskeletal and neurodegenerative groups showed more significant changes in the trend analyses. Conclusions: This information can be useful for policy makers when planning health promotion and prevention policies addressing modifiable risk factors in health.

Download Full-text

Obstacles and Challenges of Business Succession in Central Europe

Journal of International Business Research and Marketing ◽

10.18775/jibrm.1849-8558.2015.45.3004 ◽

2019 ◽

Vol 4 (5) ◽

pp. 24-29 ◽

Cited By ~ 1

Author(s):

Jasmin Schiefer ◽

Margarethe Überwimmer ◽

Robert Füreder ◽

Yasel Costa

Keyword(s):

Central Europe ◽

Social Issues ◽

European Countries ◽

Eastern European ◽

Public Authorities ◽

Policy Makers ◽

Innovation Potential ◽

Private Entrepreneurs ◽

Eastern European Countries ◽

Business Succession

The transfer of a business to the next generation is a very important issue entailing several different social and economic influences. Failed business successions cause a loss of jobs, company knowledge and innovation potential. Creating an environment where business transfer is supported should therefore be of major importance for company owners and for policy makers. For better succession planning it is important to know the obstacles and challenges associated with business succession. Especially Eastern European countries face many challenges as these countries have no experience in business succession. To analyze the obstacles and challenges of business succession in Central Europe, three Eastern countries (CZ, SK and PL) with no experience in business succession were analyzed and compared to Austria where half of family businesses are at least in their second generation. Literature analysis and two focus groups with stakeholders (local public authorities and private entrepreneurs) were undertaken in all four countries. The results show that one of the main obstacles and challenges for business succession is the absence of a successor. Especially in Austria, this is recognized as the main obstacle. The Eastern countries (CZ, SK and PL) face different challenges to Austria that can mainly be explained by the lack of experience and supporting schemes for business succession. Especially knowledge and awareness related obstacles play an important role in Eastern European countries. Business succession is an individual process involving many emotions; therefore psychological and social issues are perceived as a huge obstacle in each analyzed country. Austria has a lot of experience with successful business transfers and offers various support mechanisms. However, many similar problems to Eastern countries were detected. A change of the business succession environment and the raising of awareness of the topic is therefore necessary in all investigated countries.

Download Full-text

Two Models of Primary Health Care Development: Russia vs. Central and Eastern European Countries

SSRN Electronic Journal ◽

10.2139/ssrn.2937586 ◽

2017 ◽

Author(s):

Igor Sheiman

Keyword(s):

Health Care ◽

Primary Health Care ◽

European Countries ◽

Eastern European ◽

Primary Health ◽

Eastern European Countries ◽

Care Development

Download Full-text

Trends of multimorbidity in 15 European countries: a population-based study in community-dwelling adults aged 50 and over

BMC Public Health ◽

10.1186/s12889-020-10084-x ◽

2021 ◽

Vol 21 (1) ◽

Author(s):

Dyego L. B. Souza ◽

Albert Oliveras-Fabregas ◽

Eduard Minobes-Molina ◽

Marianna de Camargo Cancela ◽

Paola Galbany-Estragués ◽

...

Keyword(s):

Age Groups ◽

Population Based ◽

Community Dwelling ◽

European Countries ◽

Eastern European ◽

Policy Makers ◽

Large Variability ◽

Trend Analyses ◽

Eastern European Countries ◽

Series Study

Abstract Background The objective of this work was to analyse the prevalence trends of multimorbidity among European community-dwelling adults. Methods A temporal series study based on waves 1, 2, 4, 5, 6 and 7 of the Survey of Health, Ageing and Retirement in Europe (SHARE) was conducted, and community-dwelling participants aged 50+ (n = 274,614) from 15 European countries were selected for the period 2004–2017. Prevalence, adjusted by age, Average Annual Percentage Change (APC) and 95% confidence interval (95% CI) were all calculated. Trend analyses were realised by period, age groups and groups of diseases. Results The results showed a large variability in the prevalence of multimorbidity in adults aged 50 and over among European countries. Increase in the prevalence of multimorbidity in the countries of central Europe (Austria, Belgium, Czech Republic, France, Germany and Switzerland) and Spain in both sexes, and in the Netherlands among men. Stability was observed in northern and eastern European countries. Musculoskeletal and neurodegenerative groups showed more significant changes in the trend analyses. Conclusions This information can be useful for policy makers when planning health promotion and prevention policies addressing modifiable risk factors in health.

Download Full-text

Trends of multimorbidity in 15 European countries: a population-based study in community-dwelling adults aged 50 and over

10.21203/rs.3.rs-17055/v3 ◽

2020 ◽

Author(s):

Dyego L. B. Souza ◽

Albert Oliveras-Fabregas ◽

Eduard Minobes-Molina ◽

Marianna de Camargo Cancela ◽

Paola Galbany-Estragués ◽

...

Keyword(s):

Age Groups ◽

Population Based ◽

Community Dwelling ◽

European Countries ◽

Eastern European ◽

Policy Makers ◽

Large Variability ◽

Trend Analyses ◽

Eastern European Countries ◽

Series Study

Abstract Background: The objective of this work was to analyse the prevalence trends of multimorbidity among European community-dwelling adults.Methods: A temporal series study based on waves 1, 2, 4, 5, 6 and 7 of the Survey of Health, Ageing and Retirement in Europe (SHARE) was conducted, and community-dwelling participants aged 50+ (n=274,614) from 15 European countries were selected for the period 2004-2017. Prevalence, adjusted by age, Average Annual Percentage Change (APC) and 95% confidence interval (95% CI) were all calculated. Trend analyses were realised by period, age groups and groups of diseases. Results: The results showed a large variability in the prevalence of multimorbidity in adults aged 50 and over among European countries. Increase in the prevalence of multimorbidity in the countries of central Europe (Austria, Belgium, Czech Republic, France, Germany and Switzerland) and Spain in both sexes, and in the Netherlands among men. Stability was observed in northern and eastern European countries. Musculoskeletal and neurodegenerative groups showed more significant changes in the trend analyses. Conclusions: This information can be useful for policy makers when planning health promotion and prevention policies addressing modifiable risk factors in health.

Download Full-text

Constitutional Rights to Health Care: The Consequences of Placing Limits on the Right to Health Care in Several Western and Eastern European Countries

European Journal of Health Law ◽

10.1163/15718099820522461 ◽

1998 ◽

Vol 5 (3) ◽

pp. 261-289 ◽

Cited By ~ 1

Author(s):

◽

Keyword(s):

Health Care ◽

The Netherlands ◽

Cost Containment ◽

Right To Health ◽

European Countries ◽

Constitutional Rights ◽

Eastern European ◽

Right To Health Care ◽

Eastern European Countries ◽

The Right

AbstractThis paper examines the right to health care. Various expressions of this right may be distinguished. These include both individual rights and social rights which could be based upon international treaties and constitutional rights. They may be found in national health legislation and, in some cases, in jurisprudence. To analyze the consequences of limiting the right to health care, a framework for judicial review has been developed which encompasses these expressions of the right to health care. The framework was used to examine legal and health policy developments in three Western and two Eastern European countries. In Italy and the Netherlands the right to health care is protected constitutionally (but on differing legal bases) while the United Kingdom does not have a written constitution. In contrast, Hungary and Poland have for many years seen the state take responsible for the provision, administration and allocation of health care services and the right to health care was guaranteed theoretically but not in practice because of the lack of (financial) means. However, the Polish Constitution explicitly anticipates possible limitations of the right to health care. What all these countries have in common is a cost containment perspective where the future will bring even tighter limits on what resources patients may consume. Despite differences in legal structure between these countries, where they seem to converge is on the consequences of putting limitations on the right to health care. The courts in Italy, the Netherlands and the UK have formulated conditions drawn from the acceptance that this right has to be judged within the context of limited resources. It may be concluded that finding a compromise between the right to health care and cost containment policies could also be an issue, Eastern European countries will have to face in the future.

Download Full-text

Trends of multimorbidity in 15 European countries: a population-based study in community-dwelling adults aged 50 and over

10.21203/rs.3.rs-17055/v2 ◽

2020 ◽

Author(s):

Dyego L. B. Souza ◽

Albert Oliveras-Fabregas ◽

Eduard Minobes-Molina ◽

Marianna de Camargo Cancela ◽

Paola Galbany-Estragués ◽

...

Keyword(s):

Age Groups ◽

Population Based ◽

Community Dwelling ◽

European Countries ◽

Eastern European ◽

Population Based Study ◽

Policy Makers ◽

Large Variability ◽

Eastern European Countries ◽

Series Study

Abstract Background: The objective of this work was to analyse the prevalence trends of multimorbidity among European community-dwelling adults.Methods: A temporal series study based on waves 1, 2, 4, 5, 6 and 7 of the Survey of Health, Ageing and Retirement in Europe (SHARE) was conducted, and community-dwelling participants aged 50+ (n=274,614) from 15 European countries were selected for the period 2004-2017. Prevalence, adjusted by age, Average Annual Percentage Change (APC) and 95% confidence interval (95% CI) were all calculated. Trend analyses were realised by period, age groups and groups of diseases.Results: The results showed a large variability in the prevalence of multimorbidity in adults aged 50 and over among European countries. Increase in the prevalence of multimorbidity in the countries of central Europe (Austria, Belgium, Czech Republic, France, Germany and Switzerland) and Spain in both sexes, and in the Netherlands among men. Stability was observed in northern and eastern European countries. Musculoskeletal and neurodegenerative groups showed more significant changes in the trend analyses.Conclusions: This information can be useful for policy makers when planning health promotion and prevention policies addressing modifiable risk factors in health.

Download Full-text

Comparative analysis of the access to health-care services and breast cancer therapy in 10 Eastern European countries

SAGE Open Medicine ◽

10.1177/2050312120922029 ◽

2020 ◽

Vol 8 ◽

pp. 205031212092202

Author(s):

Maria Dimitrova ◽

Dragana Lakic ◽

Guenka Petrova ◽

Semir Bešlija ◽

Josip Culig

Keyword(s):

Breast Cancer ◽

Health Care ◽

Cancer Therapy ◽

Bosnia And Herzegovina ◽

Receptor Expression ◽

European Countries ◽

Eastern European ◽

Breast Cancer Therapy ◽

Eastern European Countries

Aim: The aim of this study is to compare the differences in breast cancer therapy, health-care service practices, and their availability in ten European countries—Albania, Bosnia and Herzegovina, Bulgaria, Kosovo, Montenegro, Republic of North Macedonia, Croatia, Romania, Slovenia, and Republic of Serbia. Methods: An inquire survey was conducted among oncologists in the participating countries. The questionnaire was of qualitative character and focused on several key areas as screening practices, diagnosing, treatment, and health-care procedures utilization. The results were processed through comparative and percentage analysis. Results: All of the observed countries have national registries for breast cancer, but only in five, a mechanism of controlled action of early detection is implemented. Ninety percent of the countries have implemented in the national guidelines the European Society of Medical Oncology recommendations, while National Comprehensive Cancer Network is considered in only 50%. In all countries, digital mammography is a universal diagnostic method. Pathohistological analysis, including HER2 receptor expression and determination of the level of progesterone and estrogen receptors, is routinely performed in all countries prior to therapy. Some differences are observed in terms of FISH/CISH methods, determination of Ki-67 volume, and prognostic molecular assays. Trastuzumab is used as neo-adjuvant therapy in HER2-positive disease in all countries, while in Bosnia and Herzegovina and Croatia, only pertuzumab is used. Psychological support is integrated into the professional guidelines for treatment and monitoring in Bosnia and Herzegovina, Bulgaria, and Serbia. Conclusions: The international guidelines should be followed strictly, and some improvements in the health policies should be made in order to decrease the differences and inequalities in the availability of the breast cancer (BC) health services in the Central and Eastern European countries.

Download Full-text